Status

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed March 15, 2018; licence last revised May 29, 2021.

Natural Product Number (NPN): 80083809
Licence holder: Blue Star Nutraceuticals Inc.
Dosage form: Capsule
Route: Oral
Licensing route: Non-Traditional
First licensed: March 15, 2018
Licence last revised: May 29, 2021

Medicinal ingredients

Per dosage unit, as licensed.

Ingredient	Amount	Source and potency
Magnesium	150 mg	Magnesium aspartate
Vitamin B6	3.5 mg	Pyridoxine hydrochloride
Eurycoma Longifolia	100 mg	Root
Trigonella foenum-graecum	33.33 mg	Seed(s); 20 % Saponins; 4:1 Dry; equivalent to 133.32 mg dried herb
3,3'-Diindolylmethane	36 mg	3,3'-Diindolylmethane
Piper nigrum	1.66 mg	Fruit; 95 % Piperine; 50:1 Dry; equivalent to 83 mg dried herb
Withania somnifera	200 mg	Root
Zinc	10 mg	Zinc monomethionine

What it is licensed for

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

Helps to maintain the body's ability to metabolize nutrients. Helps to maintain proper muscle function. Helps intissue formation. Helps in connective tissue formation. Helps to maintain immune function. Source ofantioxidants. Supports testosterone production to increase muscle strength. Improves sexual desire andperformance in men. Helps increase testosterone levels.

Non-medicinal ingredients

Gelatin; Microcrystalline cellulose; Magnesium stearate

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “status”. A notice may cover another product or only some lots: read it to see what it covers.

RUZURGI (amifampridine) - Authorization StatusJanuary 20, 2023 · Drugs · New safety information - Product withdrawal
Status of ranitidine drugs in CanadaJuly 23, 2020 · Drugs